MICRO: a Registry Study in Patients With Microvascular Angina
ConditionMicrovascular Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorJohannes Gutenberg University Mainz
About this trial
The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of disease and the severity of the functional impairment in these patients, the lack of a clear definition for this disease has a potentially large clinical importance. It is important to better describe the phenotype of these patients, identify the predictors of prognosis, and determine the impact of diagnosis.
Eligibility criteria
Qualifiers
Age ≥ 18 and <85 years.
Chronic coronary syndrome (including patients with anginal equivalents)
Angina CCS class II-IV
Evidence of reversible ischemia on non-invasive testing
Disqualifiers
Pregnancy and or lactation.
Medical or psychological conditions that would jeopardize an adequate and orderly participation.
Left ventricular ejection fraction lower than 30%
Previous coronary artery bypass surgery (CABG) to all major branches in the LAD and left circumflex (LCX) territory, such that IMR cannot be measured
Trial design
Treatments tested in this trial
- Assessment of microvascular function with intracoronary hemodilution
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov